PCSK9 inhibitors reduce lipoprotein (a) production
A new study published today in JACC: Basic to Translational Science sheds light on PCSK9 inhibitors, a new class of low density lipoprotein (LDL) lowering drugs, and their impact on another risk factor for heart disease, ...
Oct 31, 2016
0
0